Proud to co-lead InduPro’s $85 million Series A financing as they leverage induced proximity to modulate disease biology towards next-generation therapeutics. This financing will enable the company to further refine the technology and to map and drug protein interactions in cancer and autoimmune disease. Congratulations, InduPro! Read more: https://bit.ly/3L2r7aR #VidaPortfolio
We’re thrilled to announce our $85 Million Series A financing and the appointment of Prakash Raman, Ph.D., as CEO to advance next-generation, proximity-based protein therapeutics for the treatment of cancer and autoimmune diseases. Learn more here: https://lnkd.in/gNhhNpEq #biotech #immunooncology #autoimmune #ADC #bispecifics
--
2moMOST EXPENSIVE LIQUID BUSINESS ITS VERY USEFUL TO HUMAN BEING FOR TREARMENT OF ALL KIND OF INFECTION AND DISEASE ANYONE INVEST FOR MY BUSINESS ITS REACH HIGH PROFIT. GIVE ME OPPORTUNITY TO LIKE KIND OF BUSINESS THEN ONLY EASY SURVEY IN THE WORLD WITHOUT MEDICINE WE COULD NOT SURVEY IN THIS WORLD THINK ABOUT THIS At the forefront of sustainable development, our business focuses on innovative eco-farming and recycling practices, transforming overlooked resources into valuable products. By harnessing the potential of cockroach farming, milking snakes and scorpions, utilizing horseshoe crab blood, and converting waste into practical uses, we aim to drive economic growth while addressing environmental challenges. Join us in revolutionizing how natural resources and waste are utilized for a greener, more prosperous future. Introduction: Campaign Overview: What We Need & What You Get: • Research & Development: Enhancing methods for efficient extraction of venom and horseshoe crab blood. • Technology Implementation: Investing in cutting-edge technology for tyre and fish waste recycling processes. • Market Expansion: Scaling our production and expanding our market reach for sustainable products.